alcaftadine
Selected indexed studies
- Comparative assessment of alcaftadine and olopatadine for allergic conjunctivitis: a meta-analysis. (Postepy Dermatol Alergol, 2024) [PMID:39877108]
- Alcaftadine for the prevention of itching associated with allergic conjunctivitis. (Ann Pharmacother, 2012) [PMID:22811343]
- Alcaftadine: a topical antihistamine for use in allergic conjunctivitis. (Drugs Today (Barc), 2011) [PMID:22348913]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- In brief: OTC alcaftadine (Lastacaft Once Daily Relief) for allergic conjunctivitis. (2022) pubmed
- Comparative assessment of alcaftadine and olopatadine for allergic conjunctivitis: a meta-analysis. (2024) pubmed
- Alcaftadine for the prevention of itching associated with allergic conjunctivitis. (2012) pubmed
- Alcaftadine: a topical antihistamine for use in allergic conjunctivitis. (2011) pubmed
- Cutaneous Calcium/Calmodulin-Dependent Protein Kinase II-γ-Positive Sympathetic Nerves Secreting Norepinephrine Dictate Psoriasis. (2024) pubmed
- Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study. (2019) pubmed
- Histamine and H1-antihistamines: celebrating a century of progress. (2011) pubmed
- Determination of antihistaminic drugs alcaftadine and olopatadine hydrochloride via ion-pairing with eosin Y as a spectrofluorimetric and spectrophotometric probe: application to dosage forms. (2024) pubmed
- Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study. (2021) pubmed
- Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis. (2015) pubmed